Summary
Plasma concentrations of endothelin, a vasoconstrictor peptide released from vascular endothelial cells, have been measured by radioimmunoassay in 100 patients with diabetes mellitus and 19 healthy subjects. The plasma immunoreactive-endothelin concentrations were found to be greatly raised in the patients with diabetes (1,880±120 fmol/l, mean±SEM) compared with the healthy subjects (540±50 fmol/l, p<0.005). The elevation of immunoreactive-endothelin could not be explained by secondary changes in blood pressure or renal disease and did not correlate with the presence of diabetic retinopathy, duration of diabetes mellitus, fasting blood glucose or serum fructosamine. Fast protein liquid chromatographic analysis of the diabetic plasma immunoreactive-endothelin showed three forms, one in a very big molecular weight position, one intermediate and one in the position of endothelin-1 itself. No material appeared in the positions of endothelin-2 and 3. Chromatographic analysis of normal plasma showed only the big molecular weight peak while material in the endothelin-1,2 or 3 positions was below detection. The elevation of endothelin in diabetic patients may be a marker of, and further exacerbate, their vascular disease.
Article PDF
Similar content being viewed by others
References
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease The Framingham study. JAMA 241: 2035–2038
Jarrett RJ, McCartney P, Keen H (1982) The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart diseases in borderline diabetics. Diabetologia 22: 79–84
Porta M, Selva ML, Molinatti P, Molinatti GM (1987) Endothelial cell function in diabetic microangiopathy. Diabetologia 30: 601–609
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415
Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, Masaki T (1988) Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85: 6964–6967
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863–2867
Ando A, Hirata Y, Schichiri M, Emori T, Marumo F (1989) Presence of immunoreactive endothelin in human plasma. FEBS Lett 245: 164–166
Hartter E, Woloszczuk W (1989) Radioimmunoassay of endothelin. Lancet I: 909
Totsune K, Mouri T, Takahashi K, Ohneda M, Sone M, Furuta T, Saito T, Yoshinaga K (1989) Immunoreactive endothelin (IRET) in plasma of hemodialysis patients. Kidney Int 35: 321 (Abstract)
Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T (1989) Plasma endothelin levels in patients with uraemia. Lancet 1: 991–992
San-Gil F, Schier GM, Moses RG, Gan IET (1985) Improved estimation of fructosamine, as a measure of glycated serum protein, with the Technicon RA-1000 analyzer. Clin Chem 31: 2005–2006
Senyk G, Nitecki DE, Spitler L, Goodman JW (1972) The immune response to glucagon in conjugated form. Immunocytochemistry 9: 92–110
Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495–496
Kanse SM, Ghatei MA, Bloom SR (1989) Endothelin binding sites in porcine aortic and rat lung membrane. Eur J Biochem 182: 175–179
Itoh Y, Yanagisawa M, Ohkubo S, Kimura C, Kosaka T, Inoue A, Ishida N, Mitsui Y, Onda H, Fujino M, Masaki T (1988) Cloning and sequence of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin. FEBS Lett 231: 440–444
Kimura S, Kurihara H, Sugiyama T, Takaku F, Yazaki Y (1988) Endothelin stimulates c-fos and c-mys expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249–252
Takahashi K, Brooks RA, Kanse SM, Ghatei MA, Kohner EM, Bloom SR (1989) Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes 38: 1200–1202
Hirata Y, Yoshimi H, Takata S, Watanabe TX, Kumagai S, Nakajima K, Sakakibara S (1988) Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 154: 868–875
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahashi, K., Ghatei, M.A., Lam, H.C. et al. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33, 306–310 (1990). https://doi.org/10.1007/BF00403325
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403325